| Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study L Monin, AG Laing, M Muñoz-Ruiz, DR McKenzie, IDM Del Barrio, ... The Lancet Oncology 22 (6), 765-778, 2021 | 610 | 2021 |
| Cytomegalovirus latency and reactivation: recent insights into an age old problem L Dupont, MB Reeves Reviews in medical virology 26 (2), 75-89, 2016 | 204 | 2016 |
| Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B. 1.1. 7 variant C Graham, J Seow, I Huettner, H Khan, N Kouphou, S Acors, H Winstone, ... Immunity 54 (6), 1276-1289. e6, 2021 | 128 | 2021 |
| Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, ... Nature microbiology 6 (11), 1433-1442, 2021 | 101 | 2021 |
| The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr L Dupont, S Bloor, JC Williamson, SM Cuesta, R Shah, A Teixeira-Silva, ... Cell host & microbe 29 (5), 792-805. e6, 2021 | 68 | 2021 |
| Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6 Y Lu, JH Stuart, C Talbot-Cooper, S Agrawal-Singh, B Huntly, AI Smid, ... Proceedings of the National Academy of Sciences 116 (24), 11997-12006, 2019 | 68 | 2019 |
| Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines L Monin-Aldama, AG Laing, M Muñoz-Ruiz, DR McKenzie, ... MedRxiv, 2021.03. 17.21253131, 2021 | 58 | 2021 |
| Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter L Dupont, L Du, M Poulter, S Choi, M McIntosh, MB Reeves Journal of Biological Chemistry 294 (35), 12901-12910, 2019 | 32 | 2019 |
| Antibody longevity and cross-neutralizing activity following SARS–CoV–2 wave 1 and B. 1.1. 7 infections L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, SR Hallett, ... medRxiv, 2021 | 11 | 2021 |
| Gene expression from unintegrated HIV-1 is restricted by the SMC5/6 complex L Dupont University of Cambridge, 2021 | | 2021 |
